SavedAdd your journal

Journals / İstanbul Tıp Dergisi / 2009 / Cilt: 10 - Sayı: 4

Evaluation of transrectal ultrasonography-guided prostate biopsy histopathological results with PSA values

Transrektal US eşliğinde yapılan prostat biyopsilerinin patolojik sonuçlarının PSA değerlerine göre değerlendirilmesi

Esra PAŞAOĞLU
A. Yüksel BARUT
Ümit DERUNDERE
İlhan N. MUTLU
M. Ali NAZLI
Pages
164–166
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However there was not significant difference with regard to PSA values between group 1 and group 2.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Indroduction: Evaluation of histopathological results of Transrectal Ultrasonography-guided prostate biopsies between Prostate Spesific Antigen (PSA) values.Materials and Methods: From July 2004 to February 2005 who underwent Transrectal Ultrasonography-guided prostate biopsy were included in this study.
📊
Key Findings & Data:Cases were divided into 3 groups according to their PSA values: Group 1 (n=88; 64%; PSA: 3.7-10.0 ng/ml), group 2 (n=30; 22%; PSA: 10.0-16.0 ng/ml), group 3 (n=18; 14%; PSA: higher than 16 ng/ml).
💡
Conclusion & Impact:However there was not significant difference with regard to PSA values between group 1 and group 2.
🔬Design:Research Article
📍Scope:2004 Verileri
⚙️Variables:Domain Parameters

Abstract

Indroduction: Evaluation of histopathological results of Transrectal Ultrasonography-guided prostate biopsies between Prostate Spesific Antigen (PSA) values.Materials and Methods: From July 2004 to February 2005 who underwent Transrectal Ultrasonography-guided prostate biopsy were included in this study. Cases were divided into 3 groups according to their PSA values: Group 1 (n=88; 64%; PSA: 3.7-10.0 ng/ml), group 2 (n=30; 22%; PSA: 10.0-16.0 ng/ml), group 3 (n=18; 14%; PSA: higher than 16 ng/ml). Histopathological results correlated with PSA values.Results: Histopathological results were low grade PIN, high grade PIN and adenocarsinoma. 14% of group 1, 17% of group 2 and 100% of group 3 had adenocarsinoma histopathologically.Conclusion: Adenocarsinoma showed significant differences about 7 times when compared with those of PSA values up to 10.0 ng/ml and over 16.0 ng/ml. However there was not significant difference with regard to PSA values between group 1 and group 2.

Özet

Giriş: Transrektal Ultrasonografi (TRUS) eşliğinde yapılmış olan prostat biyopsilerinin histopatolojik sonuçları ile Prostat Spesifik Antijen (PSA) değerleri arasındaki ilişkinin değerlendirilmesi.Gereç ve yöntem: Temmuz 2004-Şubat 2005 tarihleri arasında 136 olgu çalışmaya alındı. Olgular PSA değerlerine göre 3 gruba ayrıldı: Grup 1 (n=88; %64; PSA: 3.7-10.0 ng/ml), grup 2 (n=30; %22; PSA: 10.1-16.0 ng/ml), grup 3 (n=18; %14; PSA: 16 ng/ml zeri). Histopatolojik sonuçlarla PSA değerleri ilişkilendirildi.Bulgular: Histopatolojik tanılar low grade PIN, high grade PIN ve adenokarsinom şeklindeydi. Grup 1'deki olguların %14'ü, grup 2'deki olguların %17'si ve grup 3'deki olguların %100'ü adenokarsinom tanısı almıştı. Sonuç: PSA değeri 10.0 ng/ml'ye kadarki grup ile PSA değeri 16.0 ng/ml üzeri grup arasında adenokarsinom açısından 7 kat gibi anlamlı farklılık tesbit edilmiştir. Oysa ki grup 1 ile grup 2 arasında adenokarsinom açısından anlamlı farklılık saptanmamıştır.

🔖

Cite This Article

PAŞAOĞLU, E., BARUT, A. Y., DERUNDERE, Ü., MUTLU, İ. N., NAZLI, M. A. (2022). Evaluation of transrectal ultrasonography-guided prostate biopsy histopathological results with PSA values. İstanbul Tıp Dergisi, Cilt: 10 - Sayı: 4, 164–166. https://ajindex.com/articles/552613

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Mian B, Lehr D, Moore C, et al. Role of prostate biopsy schemes in accurate prediction of Gleason scores. Urology 2006; 67: 379-83
  2. Bulbul MA, El-Hout Y, Haddad M, et al. Pathological correlation between needle biopsy and radical prostatectomy specimen in patients with localized prostate cancer. Canadian Urol 2007; 1(3): 264-6
  3. Gomella GL, Labrie F, Gamito EJ, et al. Prostate Cancer: Risk assessment and diagnostic approaches. Rev Urol. 2001; 3 (suppl 2): 31-8
  4. Carter HB. Prostate cancers in men with low PSA levelsmust we find them? N Engl J Med 2004; 350: 2292-3
  5. Lee SE, Byun SS, Park HK, Shim HB, Ku JH. Detection of Prostate Cancer at Low and Intermediate Serum Prostate- Specific Antigen Levels in a Country with a Low Incidence of Prostate Cancer. Jpn J Clin Oncol 2006; 36 (6): 376-80
  6. Masumori N, Tsukamoto T, Kumamoto Y, Miyake H, Rhodes T, Girman CJ, et al. Japanese men have smaller prostate volumes but comparable urinary flow rates relative to American men: results of community based studies in 2 countries. J Urol 1996;155:1324-7
  7. Rifkin MM, Choi H. Implications of small, peripheral hypoechoic lesions in endorectal US of the prostate. Radiology 1988;166: 619-22
  8. Plawker MW, Fleisher JM, Vapnek EM, Macchia RJ. Current trends in prostate cancer diagnosis and staging among United States urologists. J urol 1997;158: 1853-8
  9. Elabbady AA, Khedr MM. Extended 12-core prostate biopsy increases both the detection of prostate cancer and the accuracy of Gleason score. Eur Urol 2006; 49: 49-53
  10. Toi A, Neill MG, Lockwood GA, Sweet JM, Tammasalu LA, Fleshner NE. The continuing importance of transrectal ultrasound identification of prostatic lesions. J Urol 2007; 177: 516-20
  11. Lee HY, Lee HJ, Byun SS, Lee SE, Hong SK, Kim SH. Classification of Focal Prostatic Lesions on Transrectal Ultrasound (TRUS) and the Accuracy of TRUS to Diagnose Prostate Cancer. Korean J Radiol 2009; 10: 244-51
  12. Ng LG, Yip S, Tan PH, Yuen J, Lau W, Cheng C. Improved detection rate of prostate cancer using the 10-core biopsy strategy in Singapore. Asian J of Surgery 2002; 25: 238-43
  13. Babaian RJ, Toi A, Kamoi K, et al. A comparitave analysis of sextant and extended 11-core multisite directed biopsy strategy. J Urol 2000; 163: 152-7
  14. Tan HH, Gan E, Rekhraj I, et al. Use of prostate-spesific antigen (PSA) and transrectal ultrasound (TRUS) in the diagnosis of prostate cancer-A local experience. Ann Acad Med Singapore 1995; 24: 550-6
  15. Singh H, Canto E